OR2D3 Inhibitors
OR2D3 Inhibitors are compounds that interfere with the biological processes that facilitate the function and expression of the OR2D3 protein. Brefeldin A, for instance, targets the vesicular trafficking pathways crucial for the transport of the OR2D3 protein to the cell surface. By inhibiting the ADP-ribosylation factor, Brefeldin A prevents the proper trafficking of OR2D3 to the plasma membrane, leading to a reduction in the receptor's functional activity. Similarly, Chloroquine and Sucrose can lead to the degradation or misrouting of OR2D3 by raising endosomal pH or disrupting vesicular trafficking, respectively.
Genistein and Dynasore target the phosphorylation and endocytosis processes vital for OR2D3 function. Genistein's inhibition of tyrosine kinases can prevent necessary phosphorylation events for OR2D3 internalization and recycling, while Dynasore's inhibition of dynamin decreases the internalization and recycling of the receptor. Cytochalasin D and Latrunculin A act on the cytoskeleton, disrupting actin filaments and, consequently, the trafficking of OR2D3. Lovastatin's impact on cholesterol biosynthesis can affect lipid raft integrity, where OR2D3 localizes for signaling, thus impairing itsfunction. U73122 and Alprenolol interfere with signaling cascades and cross-talk inhibition, respectively, leading to diminished OR2D3 activity. Concanavalin A can alter glycosylation, essential for OR2D3 folding and surface expression, and Colchicine disrupts microtubule polymerization, impeding OR2D3 transport and reducing its functional expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits ADP-ribosylation factor, a key molecule in vesicular trafficking processes. This inhibition prevents OR2D3 from being transported from the Golgi to the cell surface, thus reducing the receptor's presence and functional activity on the plasma membrane. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises endosomal pH, which can affect the endosomal sorting and trafficking of GPCRs like OR2D3, potentially leading to lysosomal degradation rather than recycling to the cell surface. | ||||||
Sucrose | 57-50-1 | sc-204311 sc-204311B sc-204311C sc-204311A | 0.5 kg 50 kg 100 kg 5 kg | $58.00 $2000.00 $3500.00 $250.00 | 6 | |
High concentrations of sucrose can create osmotic gradients that disrupt endocytosis and vesicular trafficking, impeding the recycling of OR2D3 to the cell surface and reducing its signaling capacity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can prevent phosphorylation events necessary for the internalization and recycling of GPCRs such as OR2D3, thereby reducing its functional expression on the cell surface. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits the GTPase activity of dynamin, a protein essential for clathrin-mediated endocytosis. This inhibition can decrease the internalization and recycling of OR2D3, reducing its functional availability. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin and prevents its polymerization, disrupting cytoskeletal dynamics. This can lead to ineffective trafficking of OR2D3 to the plasma membrane, diminishing its signaling function. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase, which is vital for cholesterol biosynthesis. Cholesterol is crucial for maintaining lipid raft integrity where OR2D3 is localized for proper signaling; its depletion can impair OR2D3 function. | ||||||
Alprenolol | 13655-52-2 | sc-507469 | 50 mg | $130.00 | ||
Alprenolol is a beta-adrenergic receptor antagonist that has been shown to non-selectively bind to other GPCRs, potentially leading to allosteric modulation or downregulation of OR2D3 function through cross-talk inhibition. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Concanavalin A is a lectin that binds to glycosylated proteins, potentially interfering with the glycosylation process essential for proper OR2D3 folding and cell surface expression, thus inhibiting its function. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin filaments, which are necessary for the vesicular trafficking of proteins. This disruption can lead to a failure of OR2D3 to be properly transported to and expressed on the plasma membrane. | ||||||